- Molecules
- 17
MedsAcross lists 17 molecules linked to Ovarian cancer, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- DocetaxelMicrotubule Inhibitor14 presentations6 brandsL01CD02
- Cyclophosphamide18 presentations1 brandL01AA01
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- PaclitaxelOrphanMicrotubule Inhibitor10 presentations8 brandsL01CD01
- CarboplatinPlatinum-based Drug6 presentations1 brandL01XA02
- LeuprolideOrphanGonadotropin Releasing Hormone Receptor Agonist23 presentations9 brandsL02AE02
- CisplatinPlatinum-based Drug5 presentations1 brandL01XA01
- HydroxyureaOrphanAntimetabolite10 presentations6 brandsL01XX05
- IfosfamideOrphanAlkylating Drug5 presentations1 brandL01AA06
- TopotecanTopoisomerase Inhibitor5 presentations5 brandsL01CE01
- OlaparibOrphanPoly(ADP-Ribose) Polymerase Inhibitor2 presentations2 brandsL01XK01
- VinorelbineVinca Alkaloid2 presentationsL01CA04
- NiraparibOrphanPoly(ADP-Ribose) Polymerase Inhibitor3 presentations2 brandsL01XK02
- MelphalanOrphanAlkylating Drug2 presentations2 brandsL01AA03
- AvelumabOrphanAntibodies1 presentation2 brandsL01FF04
- ChlorambucilAlkylating Drug1 presentation1 brandL01AA02
- Leuprorelin1 brandL02AE02
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Ovarian cancer?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.